Sanofi launches its multiple sclerosis treatment drug in India

Drug firm Sanofi today said its specialty care global business unit Sanofi Genzyme has launched its multiple sclerosis treatment drug Aubagio in India.

The drug offers patients diagnosed with multiple sclerosis the efficacy and convenience of once-a-day oral treatment, Sanofi Genzyme said in a statement.

Commenting on the development, Sanofi India MD N Rajaram said, "For over a decade Sanofi has invested in developing and delivering novel therapeutic solutions for treatment of multiple sclerosis around the world; and is now bringing Aubagio, our original research product to India."